Liheng Ma

838 total citations
33 papers, 595 citations indexed

About

Liheng Ma is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Liheng Ma has authored 33 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Liheng Ma's work include RNA modifications and cancer (6 papers), Ferroptosis and cancer prognosis (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Liheng Ma is often cited by papers focused on RNA modifications and cancer (6 papers), Ferroptosis and cancer prognosis (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Liheng Ma collaborates with scholars based in China, United States and Italy. Liheng Ma's co-authors include Weifeng Hong, Yujun Gu, Min Yu, Lei Tu, Renguo Guan, Li Liang, Guangzhe Zhao, Zhenhua Qi, Weian Zeng and Yu Zhou and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Liheng Ma

32 papers receiving 589 citations

Peers

Liheng Ma

PRM

ONCOL

IMMUN

Erandi Rajagurubandara United States

Dongxu Qiu China

Jean‐Baptiste Oudart France

Michael A. Dengler Germany

Cristina Nieto‐Jiménez Spain

Kevin Zarrabi United States

Michal Sobecki France

Xian Liu China

Jinxiang Tan China

Bin Shao China

Erandi Rajagurubandara United States

Liheng Ma

265 ×1.1

239 ×1.1

131 ×0.7

PRM

289 ×1.6

ONCOL

95 ×0.9

IMMUN

Citations per year, relative to Liheng Ma Liheng Ma (= 1×) peers Erandi Rajagurubandara

Countries citing papers authored by Liheng Ma

Since Specialization

Citations

This map shows the geographic impact of Liheng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liheng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liheng Ma more than expected).

Fields of papers citing papers by Liheng Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liheng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liheng Ma. The network helps show where Liheng Ma may publish in the future.

Co-authorship network of co-authors of Liheng Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Liheng Ma. A scholar is included among the top collaborators of Liheng Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liheng Ma. Liheng Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Bing, et al.. (2025). Machine Learning-Based CT Radiomics Model to Predict the Risk of Hip Fragility Fracture. Academic Radiology. 32(5). 2854–2862. 2 indexed citations

Wu, Mei, Yajun Ma, Yanping Xue, et al.. (2022). Quantitative assessment of articular cartilage degeneration using 3D ultrashort echo time cones adiabatic T1ρ (3D UTE-Cones-AdiabT1ρ) imaging. European Radiology. 32(9). 6178–6186. 7 indexed citations

Wang, Xiaohui, Jun Zhang, Zhijian Han, Liheng Ma, & Yumin Li. (2022). ¹⁸F-labeled Dimer-Sansalvamide A Cyclodecapeptide: A Novel Diagnostic Probe to Discriminate Pancreatic Cancer from Inflammation in a Nude Mice Model. Journal of Cancer. 13(6). 1848–1858. 8 indexed citations

Yu, Yongfeng, Peng Dong, Liheng Ma, et al.. (2021). Modelled Economic Analysis for Dacomitinib–A Cost Effectiveness Analysis in Treating Patients With EGFR-Mutation-Positive Non-Small Cell Lung Cancer in China. Frontiers in Oncology. 11. 564234–564234. 4 indexed citations

Y, Liu, et al.. (2020). The Predictive Ability of Two Triglyceride-Associated Indices for Gestational Diabetes Mellitus and Large for Gestational Age Infant Among Chinese Pregnancies: A Preliminary Cohort Study. SHILAP Revista de lepidopterología. 2 indexed citations

Hong, Weifeng, Li Liang, Yujun Gu, et al.. (2020). Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma. Molecular Therapy — Nucleic Acids. 22. 937–947. 142 indexed citations

Wang, Na, Weiguang Gu, Yuan Qiu, et al.. (2020). Molecular gene mutation profiles, TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinoma. Translational Lung Cancer Research. 9(3). 629–638. 9 indexed citations

Hong, Weifeng, et al.. (2020). Intervertebral disc degeneration associated with vertebral marrow fat, assessed using quantitative magnetic resonance imaging. Skeletal Radiology. 49(11). 1753–1763. 11 indexed citations

Hong, Weifeng, Hong Yuan, Yujun Gu, et al.. (2020). Immune-related prognosis biomarkers associated with osteosarcoma microenvironment. Cancer Cell International. 20(1). 83–83. 50 indexed citations

10.

Ma, Liheng, et al.. (2020). The value of DTI: achieving high diagnostic performance for brain metastasis. La radiologia medica. 126(2). 291–298. 10 indexed citations

11.

Tu, Lei, Renguo Guan, Yu Zhou, et al.. (2019). Assessment of the expression of the immune checkpoint molecules PD‐1, CTLA4, TIM‐3 and LAG‐3 across different cancers in relation to treatment response, tumor‐infiltrating immune cells and survival. International Journal of Cancer. 147(2). 423–439. 128 indexed citations

12.

Yu, Min, Weifeng Hong, Shiye Ruan, et al.. (2019). Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer. Frontiers in Oncology. 9. 773–773. 27 indexed citations

13.

Hong, Weifeng, Renguo Guan, Yuying Liang, et al.. (2019). Genome-wide profiling of prognosis-related alternative splicing signatures in sarcoma. Annals of Translational Medicine. 7(20). 557–557. 4 indexed citations

14.

Tang, Yuan, Nanying Che, Yang Yu, et al.. (2019). Co-occurring genetic alterations and primary EGFR T790M mutations detected by NGS in pre-TKI-treated NSCLCs. Journal of Cancer Research and Clinical Oncology. 146(2). 407–416. 7 indexed citations

15.

Zhang, Qing, Chunyan Wu, Wei Ding, et al.. (2018). Prevalence of ROS1 fusion in Chinese patients with non‐small cell lung cancer. Thoracic Cancer. 10(1). 47–53. 34 indexed citations

16.

Wang, Jinliang, et al.. (2016). IL-10-Expressing Th2 Cells Contribute to the Elevated Antibody Production in Rheumatoid Arthritis. Inflammation. 39(3). 1017–24. 14 indexed citations

17.

Li, Qiong, Bo Qiu, Wenjun Xie, et al.. (2016). Early Identification of Pathological Nonresponders to Neoadjuvant Chemoradiation Therapy by Diffusion-Weighted Magnetic Resonance Imaging in Locally Advanced Esophageal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 96(2). E189–E190. 1 indexed citations

18.

Ma, Liheng, et al.. (2013). Preliminary use of a double-echo pulse sequence with 3D ultrashort echo time in the MRI of bones and joints. Experimental and Therapeutic Medicine. 5(5). 1471–1475. 5 indexed citations

19.

Chen, Siyu, et al.. (2011). Realgar-induced apoptosis and differentiation in all-trans retinoic acid (ATRA)-sensitive NB4 and ATRA-resistant MR2 cells. International Journal of Oncology. 40(4). 1089–1096. 26 indexed citations

20.

Le, Huangying, Yong Zhang, Liheng Ma, et al.. (2008). eena Promotes Myeloid Proliferation through Stimulating ERK1/2 Phosphorylation in Zebrafish. Journal of Biological Chemistry. 283(25). 17652–17661. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact